News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

French Biotech Firm Immuno-Designed Molecules Eyes 99 Millon Euro ($120.7 Million) IPO



10/19/2005 5:11:34 PM

French biotechnology firm Immuno-Designed Molecules (IDM) aims to sell about 37.3 percent of its capital in an IPO valued at 98.8 million euros ($120.7 million), the company said on Wednesday.

Read at Reuters


comments powered by Disqus
Reuters
IDM S.A.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES